Vaccine -- The Canadian Press

By The Canadian Press

Health Canada approves Pfizer-BioNTech COVID-19 vaccine for children 5 to 11

Nov 19, 2021 | 7:51 AM

OTTAWA, ONT. – Health Canada has approved the first COVID-19 vaccine for children aged five to 11 in Canada.

Pfizer and its partner BioNTech submitted a request for approval of a child-sized dose of its mRNA vaccine for COVID-19 on Oct. 18.

READ MORE: Alberta expecting arrival of COVID vaccines for children aged 5-11 next week

The companies say the results of their trials in children show comparable safety and efficacy results to those recorded in a previous Pfizer-BioNTech study in adults aged 16 to 25.

Health Canada said it would only approve the vaccine for children if its analysis showed the benefits outweigh the potential risks.

What's Happening in Lethbridge this week: November 12-17, 2024

Nov 12, 2024

What's Happening in Lethbridge this week: November 4-10, 2024

Nov 04, 2024

What's Happening in Lethbridge this week: October 28-November 3, 2024

Oct 28, 2024

Pfizer-BioNTech has changed the formulation of the pediatric vaccine slightly, so new vaccines must be delivered to Canada before children can receive a shot.

Canada is expecting an accelerated delivery of 2.9 million child-sized doses, enough for a first dose for every child in the five to 11 age group.

(More to come)